Hematological Malignancies

Showing NaN - NaN of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematological Malignancies Trial in Worldwide (Teclistamab)

Recruiting
  • Hematological Malignancies
  • Birmingham, Alabama
  • +80 more
Jan 27, 2023

Hematological Malignancies Trial in Worldwide (Talquetamab)

Recruiting
  • Hematological Malignancies
  • Birmingham, Alabama
  • +82 more
Aug 11, 2022

Hematological Malignancies Trial in Worldwide (Talquetamab)

Recruiting
  • Hematological Malignancies
  • Birmingham, Alabama
  • +14 more
Jul 14, 2022

GVHD, Hematological Malignancies Trial in Belgium (Mycophenolate mofetil, Sirolimus)

Active, not recruiting
  • Graft-Versus-Host Disease
  • Hematological Malignancies
  • Antwerpen,, Antwerpen, Belgium
  • +12 more
Mar 22, 2022

Hematological Malignancies Trial in Belgium, Netherlands (Conditioning regimen: TBI + Fludarabine, Conditioning regimen:TLI (8

Completed
  • Hematological Malignancies
  • Conditioning regimen: TBI + Fludarabine
  • Conditioning regimen:TLI (8 Gy) + ATG
  • Leuven, Flamish Brabant, Belgium
  • +10 more
Nov 16, 2021

Hematological Malignancies Trial in Brussels, Leuven, Liege (Darbepoetin alpha (Aranesp), Iron saccharate (Venofer))

Completed
  • Hematological Malignancies
  • Darbepoetin alpha (Aranesp)
  • Iron saccharate (Venofer)
  • Brussels, Belgium
  • +3 more
Jan 8, 2010